Trends in joint arthroplasty: Minimally invasive surgery, wear-resistant materials, and biologics

Journal of Clinical Rheumatology

Volumn 13, Issue 3, 2007, Pages 153-158

  Deirmengian, Carl A ^a   Jacobs, Joshua J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; METAL; OSTEOPROTEGERIN; POLYETHYLENE;

BONE ATROPHY; CERAMIC PROSTHESIS; COMPOSITE MATERIAL; ENDOPROSTHESIS; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; KNEE ARTHROPLASTY; KNEE PROSTHESIS; MINIMALLY INVASIVE SURGERY; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; REVIEW; SURGICAL TECHNIQUE;

ARTHROPLASTY, REPLACEMENT; BIOLOGICAL MARKERS; CERAMICS; HUMANS; JOINT PROSTHESIS; METALS; OSTEOLYSIS; POLYETHYLENE; PROSTHESIS DESIGN; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 34250010874     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3180690a4f     Document Type: Review

References (32)

1. Scott RD, Volatile TB. Twelve years' experience with posterior cruciate-retaining total knee arthroplasty. Clin Orthop Relat Res. 1986;100-107.
2. Stern SH, Insall JN. Posterior stabilized prosthesis. Results after follow-up of nine to twelve years. J Bone Joint Surg Am. 1992;74:980-986.
3. Rasquinha VJ, Dua V, Rodriguez JA, et al. Fifteen-year survivorship of a collarless, cemented, normalized femoral stem in primary hybrid total hip arthroplasty with a modified third-generation cement technique. J Arthroplasty. 2003;18:86-94.
4. Laskin RS, Beksac B, Phongjunakorn A, et al. Minimally invasive total knee replacement through a mini-midvastus incision: an outcome study. Clin Orthop Relat Res. 2004;74-81.
5. Hanssen AD. The subvastus approach for total knee arthroplasty resulted in better short-term outcomes than did the parapatellar approach. J Bone Joint Surg Am. 2002;84-A:325.
6. Berger RA, Sanders S, Gerlinger T, et al. Outpatient total knee arthroplasty with a minimally invasive technique. J Arthroplasty. 2005;20:33-38.
7. Tria AJ Jr, Coon TM. Minimal incision total knee arthroplasty: early experience. Clin Orthop Relat Res. 2003;185-190.
8. Berger RA, Meneghini RM, Jacobs JJ, et al. Results of unicompartmental knee arthroplasty at a minimum of ten years of follow-up. J Bone Joint Surg Am. 2005;87:999-1006.
9. Banks SA, Fregly BJ, Boniforti F, et al. Comparing in vivo kinematics of unicondylar and biunicondylar knee replacements. Knee Surg Sports Traumatol Arthrosc. 2005;13:551-556.
10. Woolson ST, Mow CS, Syquia JF, et al. Comparison of primary total hip replacements performed with a standard incision or a mini-incision. J Bone Joint Surg Am. 2004;86-A:1353-1358.
11. Ogonda L, Wilson R, Archbold P, et al. A minimal-incision technique in total hip arthroplasty does not improve early postoperative outcomes. A prospective, randomized, controlled trial. J Bone Joint Surg Am. 2005;87:701-710.
12. Wright JM, Crockett HC, Delgado S, et al. Mini-incision for total hip arthroplasty: a prospective, controlled investigation with 5-year follow-up evaluation. J Arthroplasty. 2004;19:538-545.
13. Berger RA, Duwelius PJ. The two-incision minimally invasive total hip arthroplasty: technique and results. Orthop Clin North Am. 2004;35:163-172.
14. Nishihara T, Ishihara Y, Noguchi T, et al. Membrane IL-1 induces bone resorption in organ culture. J Immunol. 1989;143:1881-1886.
15. Yang SY, Nasser S, Markel DC, et al. Human periprosthetic tissues implanted in severe combined immunodeficient mice respond to gene transfer of a cytokine inhibitor. J Bone Joint Surg Am. 2005;87:1088-1097.
16. Boyce BF, Li P, Yao Z, et al. TNF-alpha and pathologic bone resorption. Keio J Med. 2005;54:127-131.
17. Wilkinson JM, Wilson AG, Stockley I, et al. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res. 2003;18:1995-2001.
18. Schwarz EM, Lu AP, Goater JJ, et al. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res. 2000;18:472-480.
19. Holmer P, Nielsen PT. Fracture of ceramic femoral heads in total hip arthroplasty. J Arthroplasty. 1993;8:567-571.
20. Sterner T, Schutze N, Saxler G, et al. [Effects of clinically relevant alumina ceramic, zirconia ceramic and titanium particles of different sizes and concentrations on TNF-alpha release in a human macrophage cell line.] Biomed Tech (Berl). 2004;49:340-344.
21. Yoon TR, Rowe SM, Jung ST, et al. Osteolysis in association with a total hip arthroplasty with ceramic bearing surfaces. J Bone Joint Surg Am. 1998;80:1459-1468.
22. Hallab NJ, Jacobs JJ, Skipor A, et al. Systemic metal-protein binding associated with total joint replacement arthroplasty. J Biomed Mater Res. 2000;49:353-361.
23. Hallab NJ, Anderson S, Stafford T, et al. Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res. 2005;23:384-391.
24. Jacobs JJ, Hallab NJ, Skipor AK, et al. Metal degradation products: a cause for concern in metal-metal bearings? Clin Orthop Relat Res. 2003;139-147.
25. Chiesa R, Tanzi MC, Alfonsi S, et al. Enhanced wear performance of highly crosslinked UHMWPE for artificial joints. J Biomed Mater Res. 2000;50:381-387.
26. Leung S, Naudie D, Kitamura N, et al. Computed tomography in the assessment of periacetabular osteolysis. J Bone Joint Surg Am. 2005;87:592-597.
27. Potter HG, Nestor BJ, Sofka CM, et al. Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. J Bone Joint Surg Am. 2004;86-A:1947-1954.
28. Schneider U, Breusch SJ, Termath S, et al. Increased urinary crosslink levels in aseptic loosening of total hip arthroplasty. J Arthroplasty. 1998;13:687-692.
29. Wilkinson JM, Hamer AJ, Rogers A, et al. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty. J Orthop Res. 2003;21:691-696.
30. Shanbhag AS, Hasselman CT, Rubash HE. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res. 1997;33-43.
31. Goater JJ, O'Keefe RJ, Rosier RN, et al. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res. 2002;20:169-173.
32. von Knoch F, Heckelei A, Wedemeyer C, et al. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A. 2005;75:288-294.